Over the course of three decades in the healthcare industry, I have observed a multitude of initiatives aimed at reforming our systems of care, both locally and nationally. Despite the noble intentions and well-documented evidence that substantiate these efforts, a consistent theme prevails—successful transformation often eludes us. My experience on the Board of Trustees for
Health
Recent developments at the National Institute on Aging (NIA) have raised serious concerns about research integrity in the field of neuroscience. The National Institutes of Health (NIH) announced that it found substantial evidence of research misconduct involving Eliezer Masliah, MD, who previously headed the NIA’s neuroscience division. The allegations center around the improper handling of
Hemophilia B, a genetic disorder resulting from a deficiency in factor IX, has posed significant treatment challenges for patients and healthcare providers alike. Traditionally, management of this condition involved regular prophylactic infusions of clotting factors, which, while effective, did not constitute a cure. In recent years, the advent of gene therapy has heralded a new
The intersection of insurance coverage and health outcomes remains a pivotal topic in public health discourse, particularly regarding Medicaid’s role in improving cardiovascular health in low-income populations. A recent analysis of the Oregon Health Insurance Experiment reveals nuanced insights into how Medicaid enrollment does not uniformly benefit individuals but can provide significant advantages for specific
In a recent catastrophic event that shook Lebanon, thousands of handheld devices exploded simultaneously, leading to a staggering influx of eye injuries. The gravity of the situation has put a spotlight on the medical professionals racing against time to provide care. Dr. Elias Jaradeh, an ophthalmologist based in Beirut, exemplifies this strain as he painstakingly
The pharmacy field, often viewed as a stable and essential component of healthcare, has numerous hidden struggles that affect both the employees and the safety of patients. The experiences of pharmacy professionals, particularly during the intense summer of 2016, highlight the urgent need for reforms in the workplace. Long hours, lack of breaks, and overwhelming
Recent findings from a comprehensive study presented at the ECTRIMS annual meeting highlight a troubling trend in the treatment of relapsing multiple sclerosis (MS). An analysis of French registry data indicates that women are significantly less likely than men to receive essential disease-modifying treatments (DMTs) for their condition. This disparity raises critical questions about factors
The federal government has taken a significant step in addressing the escalating costs of insulin by filing a lawsuit against three major pharmacy benefit managers (PBMs) — Caremark, Express Scripts, and OptumRx. These entities dominate the prescription drug market, handling approximately 80% of all U.S. prescriptions. The Federal Trade Commission (FTC) claims that their practices
The realm of public health is in a precarious position as the intersection of politics and science becomes increasingly pronounced. The prospect of Robert F. Kennedy Jr. influencing public health policy under a potential Trump administration raises questions about the implications for organizations like the Centers for Disease Control and Prevention (CDC) and the Food
The intersection of health, policy, and emerging research findings provides a rich terrain for inquiry, particularly in the contemporary landscape marked by rapid change and complexity. A plethora of recent studies and events reflects crucial health trends, ranging from dietary impacts on metabolic health to changes in healthcare policy and drug safety. This article endeavors